Beam Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Beam Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Beam Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $105M, a 6.63% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $105M -$7.44M -6.63% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $107M -$7.2M -6.31% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $109M -$7.14M -6.14% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $113M -$5.67M -4.78% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $112M -$3.39M -2.94% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $114M -$3.35M -2.85% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $116M +$10.6M +10.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $119M +$15.8M +15.4% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $116M +$12.4M +12% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $117M +$12.1M +11.5% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $106M -$1.25M -1.17% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $103M +$15.9M +18.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $103M +$81.4M +374% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $105M +$82.5M +361% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $107M +$84.7M +383% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $86.9M +$67.9M +358% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $21.8M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $22.9M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $22.1M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $19M Dec 31, 2019 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.